Business Standard

Brokerages are betting on pharma stocks with India focus: Analysts

While domestic growth is pegged at double digits, recovery in the US may take a couple of quarters

Lab test, research, r&d, chemicals, medical research, vaccine, health, pharma
Premium

Representative image

Ram Prasad Sahu
The only sectoral index that managed to end in the green despite the mayhem on Friday was the BSE Healthcare — with a gain of 1.2 per cent. Investors are betting on the health-care space to be the beneficiary following a worldwide alert on the new Covid variant, Omicron. Within the pharmaceutical space, brokerages are betting on domestic-oriented pharma companies as compared to larger generic players, which are witnessing multiple headwinds in the US market.

Domestic operations of Indian companies stood out on the growth parameter in the September quarter. Even as overall YoY sales growth for the sector was 7

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 28 2021 | 10:59 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com